Robert J. Lynch - Concepedia

Concepedia

Author

Robert J. Lynch

United States Military Academy

Also Known As

R J Lynch, R. J. LYNCH, R. J. Lynch, R.J. Lynch, Robert J. Lynch, Robert Lynch

56

Publications

1.5K

Citations

21

H-Index

38

Concepts

All Affiliations

United States Military Academy Merck & Co., Inc., Rahway, NJ, USA (United States)Wesleyan University

RJ

About

Robert J. Lynch is an author at United States Military Academy specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	900
2	Biochemistry	12	13	749
3	Natural Sciences	8	8	258
4	Allergy	1	1	27
5	Biomedical Engineering	1	1	50

Robert J. Lynch

×

27

Publications

1.5K

Citations

21

H-Index

	Year	Citations
Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors George D. Hartman, Melissa S. Egbertson, Wasyl Halczenko, Journal of Medicinal Chemistry Molecular PharmacologyBiochemistryDonut IconMedicineAltmetric Attention Score	1992	294
Non-Peptide Fibrinogen Receptor Antagonists. 2. Optimization of a Tyrosine Template as a Mimic for Arg-Gly-Asp Melissa S. Egbertson, C. T.‐C. CHANG, Mark E. Duggan, Journal of Medicinal Chemistry	1994	178
Nonpeptide glycoprotein IIb/IIIa inhibitors: Substituted quinazolinediones and quinazolinones as potent fibrinogen receptor antagonists Nigel J. Liverton, Donna J. Armstrong, David A. Claremon, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineMechanism Of ActionPharmacological AgentPharmacotherapy	1998	114
Evidence for a Brain Site of Melatonin Action in the White-Footed Mouse, <i>Peromyscus leucopus</i> David N. Glass, Robert J. Lynch Neuroendocrinology	1982	98
Nonpeptide glycoprotein IIb/IIIa inhibitors. 5. Antithrombotic effects of MK-0383. Joseph J. Lynch, Jacquelynn J. Cook, Gary R. Sitko, Journal of Pharmacology and Experimental Therapeutics	1995	67
Non-Peptide Glycoprotein IIb/IIIa Antagonists. 11. Design and <i>in Vivo</i> Evaluation of 3,4-Dihydro-1(1<i>H</i>)-isoquinolinone-Based Antagonists and Ethyl Ester Prodrugs John H. Hutchinson, Jacquelynn J. Cook, Karen M. Brashear, Journal of Medicinal Chemistry	1996	64
Non-Peptide Glycoprotein IIb/IIIa Inhibitors. 17. Design and Synthesis of Orally Active, Long-Acting Non-Peptide Fibrinogen Receptor Antagonists Benny C. Askew, Rodney A. Bednar, Bohumil Bednář, Journal of Medicinal Chemistry	1997	56
Synthesis and use of 3-amino-4-phenyl-2-piperidones and 4-amino-2-benzazepin-3-ones as conformationally restricted phenylalanine isosteres in renin inhibitors Stephen E. de Laszlo, Bruce L. Bush, John Doyle, Journal of Medicinal Chemistry Combinatorial ChemistryBioorganic ChemistryRenin InhibitorsConformational RestrictionsHeterocycle Chemistry	1992	55
Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitors Ann E. Weber, Thomas A. Halgren, John Doyle, Journal of Medicinal Chemistry Medicinal ChemistryPharmaceutical ScienceDrug TargetBiochemistryRenin Inhibitor Designs	1991	55
Non-Peptide GPIIb/IIIa Inhibitors. 20. Centrally Constrained Thienothiophene α-Sulfonamides Are Potent, Long Acting in Vivo Inhibitors of Platelet Aggregation Melissa S. Egbertson, Jacquelynn J. Cook, Bohumil Bednář, Journal of Medicinal Chemistry PharmacotherapyBiomedical EngineeringChemical BiologyPlatelet AggregationAdp-induced Platelet Aggregation	1999	50

Page 1